Literature DB >> 30336155

Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection.

John Isbell1, Ding Yuan2, Leonel Torrao3, Ewa Gatlik3, Laurent Hoffmann3, Peter Wipfli3.   

Abstract

Accurate determination of the free fraction of a drug in plasma can be challenging when it falls below 1% and even more so when below 0.1%. Equilibrium dialysis with diluted plasma has been used to determine unbound fraction below 1%, but some analytes are not amenable to this method. One robust alternative for accurately measuring very highly bound compounds is equilibrium gel filtration; however, radiolabeled compounds have been used with this technique to quantify the low analyte concentrations. This report examined results obtained using radiolabeled compounds with liquid scintillation detection and those obtained using their nonradiolabeled analogs with liquid chromatography-tandem mass spectrometry detection. The 2 methods provided comparable results over the range of 0.005%-4% free, with a slope of 1.0 and a R2 = 0.93. These results demonstrate that equilibrium gel filtration with liquid chromatography-tandem mass spectrometry detection can be used earlier in the drug discovery process to determine the unbound fraction of highly bound drugs and may help obviate the need for radiolabeled compound.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords:  HPLC; albumin; alpha 1-acid glycoprotein; liquid chromatography-mass spectrometry (LC-MS); protein binding; scintillation spectrometry

Mesh:

Substances:

Year:  2018        PMID: 30336155     DOI: 10.1016/j.xphs.2018.10.004

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Consideration of the Unbound Drug Concentration in Enzyme Kinetics.

Authors:  Nigel J Waters; R Scott Obach; Li Di
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.

Authors:  Hifza Ahmed; Felix Bergmann; Markus Zeitlinger
Journal:  Antibiotics (Basel)       Date:  2022-07-08

3.  HPLC-MS/MS coupled with equilibrium dialysis method for quantification of free drug concentration of pazopanib in plasma.

Authors:  Yi Long Toh; Yi Yun Pang; Maung Shwe; Ravindran Kanesvaran; Chee Keong Toh; Alexandre Chan; Han Kiat Ho
Journal:  Heliyon       Date:  2020-04-27

4.  Assessment of Metabolic Interaction between Repaglinide and Quercetin via Mixed Inhibition in the Liver: In Vitro and In Vivo.

Authors:  Ji-Min Kim; Seong-Wook Seo; Dong-Gyun Han; Hwayoung Yun; In-Soo Yoon
Journal:  Pharmaceutics       Date:  2021-05-23       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.